🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: GI198745 0.5 mg

Found 51 matching trials

Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin HCl Combination Capsule in Fed State

PHASE1

The purpose of this study is to assess the bioequivalence of the second gen...

Status

Completed

Location

GSK Investigational Site

Start Date

2014-02-11

Trial ID

NCT02058576

Treatments Being Tested

Commercially available combination of dutasteride 0.5 mg and tamsulosin HCL 0.4 mg Second generation dutasteride 0.5 mg and tamsulosin HCL 0.4 mg combination capsule

Study of Enzalutamide (Formerly MDV3100) as a Neoadjuvant Therapy for Patients Undergoing Prostatectomy for Localized Prostate Cancer

PHASE2

The purpose of this study is to determine if enzalutamide is an effective t...

Status

Completed

Location

Multiple Locations

Start Date

2012-03-31

Trial ID

NCT01547299

Treatments Being Tested

Enzalutamide Leuprolide Dutasteride

A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) to Find a Formulation Which is Bioequivalent to Harnal-D Tablets (Tamsulosin Hydrochloride, 0.2mg) in Healthy Male Subjects From North East Asia

PHASE1

This study is an open-label, randomized, single dose, multi-stage, cross-ov...

Status

Completed

Location

GSK Investigational Site

Start Date

2011-11-06

Trial ID

NCT01495026

Treatments Being Tested

Dutasteride (0.5mg, fasted state)Dutasteride (0.5mg, fed state)Fixed dose combination capsule containing dutasteride 0.5mg and tamsulosin 0.2mg (fasted state)Fixed dose combination capsule containing dutasteride 0.5mg and tamsulosin 0.2mg (fasted state)Fixed dose combination capsule containing dutasteride 0.5mg and tamsulosin 0.2mg (fasted state)Fixed dose combination capsule containing dutasteride 0.5mg and tamsulosin 0.2mg (fed state)Harnal-D Tablets with water (fasted state)Harnal-D Tablets with water (fed state)Harnal-D tablets without water (fasted state)

Effect of Different Dosing Regimens of Tadalafil or Tamsulosin Combined With 5α-Reductase Inhibitors on Urinary and Sexual Outcomes in Benign Prostatic Hyperplasia

PHASE4

Benign prostatic hyperplasia (BPH) is a common condition among aging men th...

Status

Completed

Location

Beni-Suef University Hospital

Start Date

TBD

Trial ID

NCT07715448

Treatments Being Tested

Tamsulosin Tadalafil 5-Alpha Reductase Inhibitor

Study to Compare the Efficacy and Safety of Combination Treatment With Dutasteride and Tamsulosin With Tamsulosin Monotherapy, in Men With Moderate to Severe Benign Prostatic Hyperplasia

PHASE3

This is a multicentre, randomised, double-blind, parallel group study in As...

Status

Completed

Location

GSK Investigational Site

Start Date

2014-02-10

Trial ID

NCT02058368

Treatments Being Tested

Dutasteride 0.5mg capsules Dutasteride placebo capsules Tamsulosin 0.2mg tablets Disintegrating placebo tamsulosin tablet

Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasia

PHASE4

Open-label, 6 month-treatment with the IP in all subjects. - Sample size: A...

Status

Terminated

Location

GSK Investigational Site

Start Date

2012-06-29

Trial ID

NCT01673490

Treatments Being Tested

Dutasteride/Tamsulosin

Dutasteride to Treat Spinal and Bulbar Muscular Atrophy (SBMA)

PHASE2

This study will determine if the drug dutasteride can improve weakness, mob...

Status

Completed

Location

National Institutes of Health Clinical Center, 9000 Rockville Pike

Start Date

2006-03

Trial ID

NCT00303446

Treatments Being Tested

Dutasteride Placebo

Sexual Function in Men Receiving Dutasteride for Androgenetic Alopecia

PHASE3

Treatment of male pattern hair loss (MPHL) or androgenetic alopecia (AGA) w...

Status

Completed

Location

GSK Investigational Site

Start Date

2014-07-02

Trial ID

NCT02014584

Treatments Being Tested

Dutasteride Placebo

Bioequivalence Study of Dutasteride Five 0.1 mg and One 0.5 mg Soft Gelatin Capsules in Healthy Male Volunteers

PHASE1

The aim of this study is to determine the bioequivalence of 5 x 0.1 milligr...

Status

Completed

Location

GSK Investigational Site

Start Date

2013-09-23

Trial ID

NCT01929330

Treatments Being Tested

GI198745 0.1 mg GI198745 0.5 mg

Testosterone and Its Metabolites in GID

PHASE3

The purposes of this study are: * to determine the role of testosterone ve...

Status

Completed

Location

Clinic of Obstetrics and Gynecology - S. Orsola Hospital

Start Date

2005-05

Trial ID

NCT00146146

Treatments Being Tested

testosterone undecanoate alone testosterone undecanoate plus letrozole testosterone undecanoate plus dutasteride

Previous Next